News & Updates
Filter by Specialty:
Show Multimedia Only
Patient preferences must be considered for anticoagulation duration in unprovoked VTE
14 Jul 2023
Shared decision making should be practiced by clinicians to include patient preferences and values when taking into account the duration of anticoagulant therapy for unprovoked venous thromboembolism (VTE), suggests a study.
Patient preferences must be considered for anticoagulation duration in unprovoked VTE
14 Jul 2023
Ustekinumab shows efficacy in Asians with plaque psoriasis
14 Jul 2023
byStephen Padilla
Asian patients with moderate to severe plaque psoriasis may benefit from ustekinumab therapy, which has been shown to be both safe and effective in a Singapore study.
